Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 276

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 276
---
083equal to 5% of Valent Net Sales (as defined in the Valent Assignment Agreement). Related party payables As of September 30, 2024, there is an aggregate amount of $ 50(June 30, 2024 - $ 52) payable to the Company’s officers and directors for fees, expenses, and other liabilities. F- 40

8 Stockholders’ equity

Preferred stock

Series C Preferred Stock

|                                                        |     | Series C Preferred Stock |         |   |     |                 |        |   |
|                                                        |     | Numberof shares          |         |   |     | $(in thousands) |        |   |
| Balance - June 30, 2024                                |     |                          |  13,668 |   |     |                 |  9,973 |   |
| Conversion of Series C Preferred stock to common stock |     |                          | (13,668 | ) |     |                 | (9,973 | ) |
| Balance - September 30, 2024                           |     |                          |       — |   |     |                 |      — |   |

In August 2020, the Company issued 25,028 shares of Series C Convertible Preferred Stock (the “Series C Preferred Stock”) in three separate closings of a private placement (Series C-1, C-2, and C-3). Each share of Series C Preferred Stock was issued at a purchase price of $ 1,000 per share and is convertible into shares of common stock based on the respective conversion prices which were determined at the closing of each round of the private placement. The conversion prices for the Series C-1 Preferred Stock, Series C-2 Preferred Stock, and the Series C-3 Preferred Stock were $ 2,030.00 , $ 2,124.50 , and $ 2,012.50 , respectively. Subject to ownership limitations, the owners of the Series C-1 Preferred Stock, the Series C-2 Preferred Stock, and the Series C-3 Preferred Stock were entitled to receive dividends, payable in shares of common stock at a rate of 10 %, 15 %, 20 % and 25 %, respectively, of the number of shares of common stock issuable upon conversion of the Series C Preferred Stock, on the 12th, 24th, 36th and 48th month, anniversary of the initial closing of the private placement. The Company paid the